Brokerages expect diagnostic majors to sustain volume growth through FY27, aided by robust demand and stable pricing, though the recent stock rally may cap upside
Online players had kept rates low, but with Covid time volumes gone, the trend is changing
Competitive pricing, however, is here to stay, feel analysts and some industry insiders
The shares of top diagnostic chains in the country shot up amidst volatile market conditions
While the organised sector is gaining market share, there are near-term challenges for Dr Lal Pathlabs and Thyrocare